Nichole Reisdorph
Concepts (642)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 26 | 2025 | 704 | 4.500 |
Why?
| | Mass Spectrometry | 23 | 2025 | 739 | 2.250 |
Why?
| | Metabolome | 12 | 2023 | 366 | 2.040 |
Why?
| | Tandem Mass Spectrometry | 10 | 2023 | 566 | 1.790 |
Why?
| | Bronchoalveolar Lavage Fluid | 9 | 2024 | 650 | 1.370 |
Why?
| | Ion Mobility Spectrometry | 3 | 2020 | 5 | 1.330 |
Why?
| | Proteomics | 12 | 2019 | 1134 | 1.270 |
Why?
| | Asthma | 12 | 2024 | 1913 | 1.220 |
Why?
| | Proteome | 8 | 2019 | 483 | 1.170 |
Why?
| | Chromatography, High Pressure Liquid | 11 | 2025 | 593 | 1.150 |
Why?
| | Lipids | 6 | 2022 | 689 | 1.100 |
Why?
| | Ozone | 6 | 2025 | 133 | 1.030 |
Why?
| | Diet, Mediterranean | 2 | 2024 | 29 | 1.010 |
Why?
| | Tea | 1 | 2025 | 16 | 0.900 |
Why?
| | Phytochemicals | 1 | 2025 | 13 | 0.900 |
Why?
| | Research | 2 | 2018 | 455 | 0.860 |
Why?
| | Biomarkers | 25 | 2024 | 4174 | 0.840 |
Why?
| | Amino Acids | 4 | 2020 | 497 | 0.830 |
Why?
| | Chromatography, Liquid | 11 | 2025 | 453 | 0.830 |
Why?
| | Lung | 14 | 2025 | 4134 | 0.800 |
Why?
| | Eicosanoids | 4 | 2022 | 63 | 0.750 |
Why?
| | Blood Chemical Analysis | 3 | 2014 | 110 | 0.730 |
Why?
| | Metabolic Networks and Pathways | 5 | 2021 | 184 | 0.720 |
Why?
| | Benz(a)Anthracenes | 1 | 2021 | 2 | 0.700 |
Why?
| | Benzopyrenes | 1 | 2021 | 4 | 0.700 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 7 | 2022 | 1049 | 0.700 |
Why?
| | Polycyclic Aromatic Hydrocarbons | 1 | 2021 | 27 | 0.680 |
Why?
| | Animals | 60 | 2025 | 37657 | 0.680 |
Why?
| | Mice | 42 | 2025 | 18048 | 0.670 |
Why?
| | Pneumonia | 5 | 2025 | 656 | 0.660 |
Why?
| | Liquid-Liquid Extraction | 3 | 2018 | 14 | 0.650 |
Why?
| | Docosahexaenoic Acids | 5 | 2025 | 86 | 0.640 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 13 | 0.640 |
Why?
| | Breath Tests | 2 | 2017 | 76 | 0.620 |
Why?
| | Food | 2 | 2020 | 163 | 0.610 |
Why?
| | Cardiovascular Diseases | 4 | 2024 | 2087 | 0.610 |
Why?
| | Organic Chemicals | 1 | 2020 | 127 | 0.580 |
Why?
| | Phosphopeptides | 1 | 2018 | 20 | 0.580 |
Why?
| | Peptide Mapping | 1 | 2018 | 65 | 0.570 |
Why?
| | Databases, Chemical | 1 | 2018 | 9 | 0.570 |
Why?
| | Eicosapentaenoic Acid | 3 | 2024 | 38 | 0.560 |
Why?
| | Monocytes | 1 | 2021 | 579 | 0.550 |
Why?
| | Tyrosine | 1 | 2018 | 228 | 0.540 |
Why?
| | Isotope Labeling | 1 | 2018 | 81 | 0.540 |
Why?
| | Hypersensitivity | 4 | 2022 | 257 | 0.520 |
Why?
| | Tobacco Smoke Pollution | 2 | 2017 | 256 | 0.510 |
Why?
| | Gastrointestinal Microbiome | 1 | 2025 | 725 | 0.510 |
Why?
| | Pulmonary Emphysema | 4 | 2019 | 312 | 0.510 |
Why?
| | Skin | 3 | 2018 | 765 | 0.510 |
Why?
| | Plasma | 2 | 2017 | 220 | 0.500 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2018 | 429 | 0.500 |
Why?
| | Humans | 75 | 2025 | 141187 | 0.500 |
Why?
| | Smoking | 7 | 2020 | 1601 | 0.490 |
Why?
| | Macrophages | 2 | 2021 | 1561 | 0.480 |
Why?
| | Mice, Inbred C57BL | 14 | 2025 | 5887 | 0.470 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2020 | 136 | 0.470 |
Why?
| | Saliva | 1 | 2017 | 245 | 0.460 |
Why?
| | Dietary Supplements | 7 | 2025 | 566 | 0.460 |
Why?
| | Glycerophospholipids | 4 | 2022 | 36 | 0.450 |
Why?
| | Peptides | 4 | 2019 | 978 | 0.440 |
Why?
| | Salmon | 2 | 2025 | 21 | 0.440 |
Why?
| | Seafood | 2 | 2025 | 27 | 0.440 |
Why?
| | Nerve Tissue Proteins | 1 | 2018 | 601 | 0.440 |
Why?
| | Computational Biology | 3 | 2020 | 661 | 0.430 |
Why?
| | Leukotriene E4 | 3 | 2013 | 24 | 0.420 |
Why?
| | Alveolar Epithelial Cells | 3 | 2019 | 115 | 0.420 |
Why?
| | Mitochondria | 5 | 2023 | 967 | 0.420 |
Why?
| | Cell Differentiation | 2 | 2021 | 2003 | 0.410 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2020 | 181 | 0.400 |
Why?
| | Chromatography, Reverse-Phase | 1 | 2013 | 28 | 0.400 |
Why?
| | Microbiota | 4 | 2022 | 767 | 0.380 |
Why?
| | Bronchoalveolar Lavage | 3 | 2018 | 92 | 0.380 |
Why?
| | Cholesterol | 3 | 2024 | 405 | 0.370 |
Why?
| | Autoantigens | 4 | 2019 | 422 | 0.360 |
Why?
| | Sirtuin 3 | 3 | 2023 | 61 | 0.360 |
Why?
| | Vitamins | 2 | 2025 | 184 | 0.360 |
Why?
| | Endocannabinoids | 2 | 2022 | 69 | 0.360 |
Why?
| | Software | 4 | 2020 | 676 | 0.360 |
Why?
| | Male | 45 | 2025 | 69783 | 0.350 |
Why?
| | Liver | 4 | 2020 | 1819 | 0.350 |
Why?
| | Reproducibility of Results | 7 | 2020 | 3348 | 0.330 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2022 | 142 | 0.320 |
Why?
| | Sleep Deprivation | 2 | 2023 | 200 | 0.320 |
Why?
| | Transcriptome | 4 | 2022 | 1003 | 0.310 |
Why?
| | Immunoenzyme Techniques | 1 | 2009 | 209 | 0.300 |
Why?
| | Species Specificity | 2 | 2020 | 583 | 0.300 |
Why?
| | Analgesia | 1 | 2010 | 102 | 0.300 |
Why?
| | Kainic Acid | 2 | 2018 | 34 | 0.270 |
Why?
| | Minerals | 2 | 2025 | 44 | 0.270 |
Why?
| | Workflow | 2 | 2020 | 171 | 0.270 |
Why?
| | Diet | 4 | 2024 | 1282 | 0.270 |
Why?
| | Sensitivity and Specificity | 5 | 2017 | 1973 | 0.270 |
Why?
| | Urinalysis | 2 | 2020 | 77 | 0.260 |
Why?
| | Interleukin-13 | 3 | 2024 | 149 | 0.260 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2025 | 557 | 0.260 |
Why?
| | Chromatography, Ion Exchange | 1 | 2007 | 53 | 0.260 |
Why?
| | Female | 38 | 2025 | 75515 | 0.260 |
Why?
| | Obesity | 7 | 2024 | 3004 | 0.250 |
Why?
| | Inflammation Mediators | 2 | 2020 | 519 | 0.250 |
Why?
| | Mitochondrial Proteins | 2 | 2019 | 261 | 0.250 |
Why?
| | Disease Models, Animal | 9 | 2025 | 4404 | 0.250 |
Why?
| | Blood Pressure | 4 | 2020 | 1748 | 0.250 |
Why?
| | Middle Aged | 20 | 2025 | 34434 | 0.250 |
Why?
| | Mucus | 2 | 2024 | 78 | 0.240 |
Why?
| | Receptors, Lipoxin | 1 | 2025 | 5 | 0.240 |
Why?
| | Receptors, Formyl Peptide | 1 | 2025 | 12 | 0.240 |
Why?
| | Data Interpretation, Statistical | 2 | 2018 | 376 | 0.240 |
Why?
| | Diet, High-Fat | 3 | 2022 | 253 | 0.240 |
Why?
| | Pulmonary Medicine | 1 | 2006 | 83 | 0.240 |
Why?
| | Dermatitis, Atopic | 3 | 2018 | 331 | 0.230 |
Why?
| | Body Fluids | 2 | 2017 | 70 | 0.230 |
Why?
| | Food Analysis | 1 | 2025 | 26 | 0.230 |
Why?
| | Sodium Nitrite | 2 | 2015 | 39 | 0.230 |
Why?
| | Fish Products | 1 | 2025 | 7 | 0.230 |
Why?
| | Receptors, G-Protein-Coupled | 3 | 2021 | 226 | 0.230 |
Why?
| | Germ-Free Life | 1 | 2025 | 33 | 0.230 |
Why?
| | Fetal Growth Retardation | 2 | 2021 | 577 | 0.230 |
Why?
| | Metals, Heavy | 1 | 2025 | 31 | 0.220 |
Why?
| | Cell Line | 7 | 2024 | 2885 | 0.220 |
Why?
| | Flavoproteins | 1 | 2004 | 8 | 0.220 |
Why?
| | Photoreceptor Cells, Invertebrate | 1 | 2004 | 4 | 0.220 |
Why?
| | Chlamydomonas reinhardtii | 1 | 2004 | 8 | 0.220 |
Why?
| | Ethanol | 2 | 2019 | 629 | 0.220 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2016 | 1110 | 0.210 |
Why?
| | Membrane Microdomains | 1 | 2024 | 35 | 0.210 |
Why?
| | Fatty Acids, Unsaturated | 2 | 2022 | 98 | 0.210 |
Why?
| | Agaricus | 1 | 2023 | 3 | 0.210 |
Why?
| | Lectins | 1 | 2024 | 46 | 0.210 |
Why?
| | GPI-Linked Proteins | 1 | 2024 | 76 | 0.210 |
Why?
| | Solid Phase Extraction | 2 | 2014 | 25 | 0.210 |
Why?
| | Mucin 5AC | 1 | 2024 | 70 | 0.210 |
Why?
| | Pilot Projects | 6 | 2022 | 1820 | 0.210 |
Why?
| | Islet Amyloid Polypeptide | 2 | 2016 | 48 | 0.210 |
Why?
| | Feces | 2 | 2025 | 504 | 0.210 |
Why?
| | Eye Proteins | 1 | 2004 | 93 | 0.210 |
Why?
| | Oxadiazoles | 1 | 2003 | 33 | 0.210 |
Why?
| | Sleep | 4 | 2023 | 877 | 0.210 |
Why?
| | Mice, Knockout | 10 | 2025 | 3068 | 0.210 |
Why?
| | Proteins | 3 | 2017 | 1010 | 0.210 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2020 | 145 | 0.200 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2003 | 59 | 0.200 |
Why?
| | Isoxazoles | 1 | 2003 | 54 | 0.200 |
Why?
| | Rhinovirus | 1 | 2003 | 58 | 0.200 |
Why?
| | Capsid | 1 | 2003 | 91 | 0.200 |
Why?
| | Plant Extracts | 1 | 2025 | 209 | 0.190 |
Why?
| | Arachidonic Acids | 1 | 2022 | 63 | 0.190 |
Why?
| | Acylation | 2 | 2019 | 31 | 0.190 |
Why?
| | Prostaglandins | 2 | 2022 | 101 | 0.190 |
Why?
| | Drosophila Proteins | 1 | 2004 | 204 | 0.190 |
Why?
| | Myocardium | 3 | 2019 | 928 | 0.190 |
Why?
| | Acute Lung Injury | 1 | 2025 | 304 | 0.180 |
Why?
| | Cells, Cultured | 6 | 2021 | 4208 | 0.180 |
Why?
| | Lipoxins | 1 | 2021 | 10 | 0.180 |
Why?
| | Oxidative Stress | 4 | 2021 | 1330 | 0.180 |
Why?
| | Linear Models | 2 | 2018 | 857 | 0.180 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 2 | 2020 | 34 | 0.180 |
Why?
| | Citrate (si)-Synthase | 1 | 2021 | 60 | 0.180 |
Why?
| | Bacterial Toxins | 1 | 2022 | 104 | 0.180 |
Why?
| | Hippocampus | 2 | 2018 | 939 | 0.180 |
Why?
| | Liver Diseases, Alcoholic | 2 | 2019 | 94 | 0.180 |
Why?
| | Orthomyxoviridae Infections | 2 | 2024 | 68 | 0.180 |
Why?
| | Dinoprostone | 1 | 2022 | 191 | 0.180 |
Why?
| | Quantitative Trait Loci | 2 | 2021 | 364 | 0.180 |
Why?
| | Brain Chemistry | 1 | 2021 | 117 | 0.180 |
Why?
| | Insulin-Secreting Cells | 3 | 2020 | 382 | 0.170 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2022 | 151 | 0.170 |
Why?
| | Calcifediol | 2 | 2022 | 33 | 0.170 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2021 | 25 | 0.170 |
Why?
| | Sepsis | 1 | 2007 | 616 | 0.170 |
Why?
| | Receptors, Scavenger | 1 | 2021 | 23 | 0.170 |
Why?
| | Amidohydrolases | 1 | 2021 | 32 | 0.170 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2021 | 52 | 0.170 |
Why?
| | Macrophages, Alveolar | 1 | 2024 | 396 | 0.170 |
Why?
| | Neuroprotection | 1 | 2021 | 43 | 0.170 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2020 | 32 | 0.170 |
Why?
| | Vitamin D Deficiency | 1 | 2022 | 190 | 0.170 |
Why?
| | Lipid Metabolism | 3 | 2018 | 528 | 0.170 |
Why?
| | Leukocytes, Mononuclear | 4 | 2022 | 573 | 0.170 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 48 | 0.170 |
Why?
| | Oxylipins | 3 | 2025 | 41 | 0.160 |
Why?
| | Nasal Polyps | 1 | 2020 | 61 | 0.160 |
Why?
| | Melatonin | 1 | 2021 | 157 | 0.160 |
Why?
| | Vesicular Transport Proteins | 1 | 2020 | 85 | 0.160 |
Why?
| | Biotransformation | 1 | 2020 | 62 | 0.160 |
Why?
| | Vital Capacity | 2 | 2018 | 312 | 0.160 |
Why?
| | Phosphorylation | 4 | 2019 | 1768 | 0.160 |
Why?
| | Phosphatidylcholines | 1 | 2020 | 136 | 0.160 |
Why?
| | Anti-Citrullinated Protein Antibodies | 1 | 2021 | 116 | 0.160 |
Why?
| | Neuroprotective Agents | 1 | 2021 | 139 | 0.160 |
Why?
| | Succinic Acid | 1 | 2019 | 41 | 0.160 |
Why?
| | Protein Deglycase DJ-1 | 1 | 2019 | 15 | 0.160 |
Why?
| | Myofibrils | 1 | 2019 | 49 | 0.160 |
Why?
| | Cross-Over Studies | 2 | 2020 | 578 | 0.160 |
Why?
| | Umbilical Arteries | 1 | 2020 | 54 | 0.160 |
Why?
| | Tubulin | 1 | 2020 | 146 | 0.150 |
Why?
| | Lung Injury | 1 | 2022 | 227 | 0.150 |
Why?
| | Anthracenes | 1 | 2019 | 32 | 0.150 |
Why?
| | Bariatric Surgery | 1 | 2022 | 218 | 0.150 |
Why?
| | Hyperinsulinism | 1 | 2020 | 122 | 0.150 |
Why?
| | Epithelium | 1 | 2020 | 316 | 0.150 |
Why?
| | Islets of Langerhans | 2 | 2019 | 804 | 0.150 |
Why?
| | Uterine Artery | 1 | 2020 | 75 | 0.150 |
Why?
| | Insulin | 3 | 2022 | 2482 | 0.150 |
Why?
| | Fluorenes | 1 | 2019 | 45 | 0.150 |
Why?
| | Neurodegenerative Diseases | 1 | 2021 | 140 | 0.150 |
Why?
| | Liposomes | 1 | 2020 | 224 | 0.150 |
Why?
| | Aging | 3 | 2023 | 1892 | 0.150 |
Why?
| | DNA End-Joining Repair | 1 | 2019 | 22 | 0.150 |
Why?
| | Inhalation Exposure | 2 | 2021 | 108 | 0.150 |
Why?
| | Rhinitis | 1 | 2020 | 173 | 0.150 |
Why?
| | Dietary Proteins | 1 | 2020 | 136 | 0.150 |
Why?
| | Aged | 11 | 2023 | 24574 | 0.150 |
Why?
| | Synapses | 1 | 2022 | 428 | 0.140 |
Why?
| | Trypsin | 1 | 2018 | 76 | 0.140 |
Why?
| | Spleen | 1 | 2020 | 525 | 0.140 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2018 | 41 | 0.140 |
Why?
| | B-Lymphocyte Subsets | 1 | 2018 | 77 | 0.140 |
Why?
| | Leukotrienes | 1 | 2018 | 36 | 0.140 |
Why?
| | Gene Expression | 4 | 2020 | 1491 | 0.140 |
Why?
| | C-Peptide | 2 | 2016 | 167 | 0.140 |
Why?
| | Cysteine | 1 | 2019 | 205 | 0.140 |
Why?
| | Adult | 15 | 2025 | 39177 | 0.140 |
Why?
| | Microtubules | 1 | 2020 | 285 | 0.140 |
Why?
| | Bacteria | 1 | 2025 | 881 | 0.140 |
Why?
| | Epilepsy, Temporal Lobe | 1 | 2018 | 38 | 0.140 |
Why?
| | Diet, Ketogenic | 1 | 2018 | 36 | 0.140 |
Why?
| | Limit of Detection | 1 | 2018 | 92 | 0.140 |
Why?
| | Myocardial Ischemia | 1 | 2019 | 280 | 0.140 |
Why?
| | Sinusitis | 1 | 2020 | 239 | 0.140 |
Why?
| | NAD | 1 | 2018 | 78 | 0.140 |
Why?
| | Flow Injection Analysis | 1 | 2017 | 6 | 0.140 |
Why?
| | Fatty Acids, Essential | 1 | 2017 | 3 | 0.130 |
Why?
| | Niacinamide | 1 | 2018 | 82 | 0.130 |
Why?
| | Inflammasomes | 1 | 2018 | 134 | 0.130 |
Why?
| | Kynurenine | 1 | 2018 | 118 | 0.130 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 338 | 0.130 |
Why?
| | Adiponectin | 2 | 2022 | 241 | 0.130 |
Why?
| | Sample Size | 1 | 2017 | 128 | 0.130 |
Why?
| | Health | 1 | 2017 | 84 | 0.130 |
Why?
| | Hydrolases | 1 | 2017 | 58 | 0.130 |
Why?
| | Interleukin-6 | 2 | 2021 | 792 | 0.130 |
Why?
| | Nerve Growth Factors | 1 | 2017 | 79 | 0.130 |
Why?
| | Autoimmunity | 2 | 2021 | 908 | 0.130 |
Why?
| | Antibodies | 1 | 2018 | 409 | 0.130 |
Why?
| | Proline | 1 | 2017 | 76 | 0.130 |
Why?
| | Disease | 1 | 2017 | 102 | 0.130 |
Why?
| | Immunophenotyping | 2 | 2018 | 329 | 0.130 |
Why?
| | Artifacts | 1 | 2017 | 133 | 0.130 |
Why?
| | Sphingolipids | 1 | 2017 | 80 | 0.130 |
Why?
| | Hyperglycemia | 1 | 2020 | 361 | 0.120 |
Why?
| | Influenza, Human | 1 | 2022 | 626 | 0.120 |
Why?
| | Actins | 1 | 2018 | 423 | 0.120 |
Why?
| | Immunity, Humoral | 1 | 2017 | 117 | 0.120 |
Why?
| | Vascular Stiffness | 2 | 2018 | 449 | 0.120 |
Why?
| | High-Throughput Screening Assays | 1 | 2017 | 157 | 0.120 |
Why?
| | Epitopes | 2 | 2016 | 477 | 0.120 |
Why?
| | Cardiomyopathies | 1 | 2019 | 330 | 0.120 |
Why?
| | Acetylation | 3 | 2023 | 245 | 0.120 |
Why?
| | Sex Characteristics | 1 | 2021 | 788 | 0.120 |
Why?
| | Emphysema | 2 | 2013 | 116 | 0.120 |
Why?
| | HEK293 Cells | 1 | 2018 | 737 | 0.120 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 3 | 2011 | 112 | 0.120 |
Why?
| | Arginine | 1 | 2017 | 260 | 0.120 |
Why?
| | Signal Transduction | 4 | 2022 | 5144 | 0.120 |
Why?
| | Cytokines | 4 | 2025 | 2098 | 0.120 |
Why?
| | Apoptosis | 4 | 2017 | 2574 | 0.120 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2016 | 184 | 0.120 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2015 | 32 | 0.110 |
Why?
| | Glycosphingolipids | 1 | 2015 | 7 | 0.110 |
Why?
| | Amino Acid Sequence | 5 | 2016 | 2158 | 0.110 |
Why?
| | Aorta | 2 | 2015 | 421 | 0.110 |
Why?
| | Electrophysiology | 1 | 2015 | 217 | 0.110 |
Why?
| | Metabolic Syndrome | 1 | 2018 | 349 | 0.110 |
Why?
| | Endoplasmic Reticulum | 1 | 2017 | 265 | 0.110 |
Why?
| | Respiratory Mucosa | 2 | 2024 | 330 | 0.110 |
Why?
| | Forensic Sciences | 1 | 2014 | 6 | 0.110 |
Why?
| | Chlorine | 1 | 2015 | 64 | 0.110 |
Why?
| | Brain | 2 | 2018 | 2858 | 0.110 |
Why?
| | Patch-Clamp Techniques | 1 | 2015 | 293 | 0.110 |
Why?
| | Carotid Arteries | 1 | 2015 | 201 | 0.110 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2016 | 199 | 0.110 |
Why?
| | Interleukin-16 | 1 | 2013 | 6 | 0.110 |
Why?
| | Cerebrospinal Fluid | 1 | 2014 | 92 | 0.100 |
Why?
| | Insulin Resistance | 1 | 2022 | 1225 | 0.100 |
Why?
| | Lipopolysaccharides | 2 | 2025 | 889 | 0.100 |
Why?
| | Leukotriene Antagonists | 1 | 2013 | 24 | 0.100 |
Why?
| | Gangliosides | 1 | 2013 | 22 | 0.100 |
Why?
| | Cholesterol Side-Chain Cleavage Enzyme | 1 | 2013 | 9 | 0.100 |
Why?
| | Methyl Ethers | 1 | 2013 | 15 | 0.100 |
Why?
| | Lung Diseases | 2 | 2013 | 794 | 0.100 |
Why?
| | Up-Regulation | 2 | 2019 | 859 | 0.100 |
Why?
| | Education | 1 | 2013 | 109 | 0.100 |
Why?
| | Diabetes Mellitus, Type 1 | 4 | 2019 | 3776 | 0.100 |
Why?
| | Adrenergic beta-Agonists | 1 | 2013 | 98 | 0.100 |
Why?
| | Smoking Cessation | 1 | 2017 | 440 | 0.100 |
Why?
| | Methanol | 1 | 2013 | 43 | 0.100 |
Why?
| | Health Status | 1 | 2018 | 823 | 0.100 |
Why?
| | Case-Control Studies | 2 | 2018 | 3588 | 0.100 |
Why?
| | Nasal Mucosa | 2 | 2024 | 106 | 0.090 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 188 | 0.090 |
Why?
| | Bronchodilator Agents | 1 | 2013 | 198 | 0.090 |
Why?
| | Alcohol Drinking | 1 | 2019 | 834 | 0.090 |
Why?
| | Arthritis, Rheumatoid | 1 | 2021 | 1176 | 0.090 |
Why?
| | Epilepsy | 1 | 2016 | 349 | 0.090 |
Why?
| | Hydroxyeicosatetraenoic Acids | 2 | 2022 | 44 | 0.090 |
Why?
| | Mice, Inbred NOD | 4 | 2016 | 600 | 0.090 |
Why?
| | B-Lymphocytes | 1 | 2017 | 858 | 0.090 |
Why?
| | Heart Diseases | 1 | 2015 | 335 | 0.090 |
Why?
| | Muscle, Skeletal | 1 | 2021 | 1752 | 0.090 |
Why?
| | Oxidation-Reduction | 3 | 2020 | 1086 | 0.090 |
Why?
| | Molecular Sequence Data | 4 | 2016 | 2929 | 0.090 |
Why?
| | Calcium | 1 | 2017 | 1187 | 0.090 |
Why?
| | Fatty Acids | 3 | 2018 | 448 | 0.090 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2013 | 344 | 0.090 |
Why?
| | Kaposi Varicelliform Eruption | 1 | 2011 | 21 | 0.090 |
Why?
| | fas Receptor | 1 | 2011 | 97 | 0.090 |
Why?
| | Ovarian Follicle | 1 | 2011 | 72 | 0.090 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2018 | 336 | 0.080 |
Why?
| | Motor Activity | 1 | 2015 | 717 | 0.080 |
Why?
| | Aged, 80 and over | 3 | 2018 | 7856 | 0.080 |
Why?
| | Anti-Asthmatic Agents | 1 | 2013 | 273 | 0.080 |
Why?
| | Pregnancy | 5 | 2025 | 7070 | 0.080 |
Why?
| | Aluminum | 1 | 2010 | 43 | 0.080 |
Why?
| | Mice, Obese | 2 | 2021 | 67 | 0.080 |
Why?
| | Dietary Fats | 2 | 2022 | 300 | 0.080 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2010 | 55 | 0.080 |
Why?
| | Rats | 4 | 2022 | 5629 | 0.080 |
Why?
| | Sarcomeres | 1 | 2010 | 94 | 0.080 |
Why?
| | E2F2 Transcription Factor | 1 | 2009 | 15 | 0.080 |
Why?
| | Toll-Like Receptor 2 | 1 | 2010 | 120 | 0.080 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2009 | 27 | 0.080 |
Why?
| | Light | 2 | 2021 | 394 | 0.080 |
Why?
| | Chromogranin A | 1 | 2010 | 42 | 0.080 |
Why?
| | Gene Expression Regulation | 3 | 2015 | 2599 | 0.080 |
Why?
| | Ovary | 1 | 2011 | 225 | 0.080 |
Why?
| | Lymphocyte Activation | 3 | 2018 | 1150 | 0.080 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2009 | 71 | 0.080 |
Why?
| | Endothelium, Vascular | 1 | 2015 | 951 | 0.070 |
Why?
| | Adjuvants, Immunologic | 1 | 2010 | 238 | 0.070 |
Why?
| | Protein C | 1 | 2009 | 54 | 0.070 |
Why?
| | Binding Sites | 2 | 2020 | 1316 | 0.070 |
Why?
| | Glycoproteins | 1 | 2010 | 356 | 0.070 |
Why?
| | Muscle Proteins | 1 | 2010 | 240 | 0.070 |
Why?
| | Sirtuins | 2 | 2019 | 39 | 0.070 |
Why?
| | Sphingomyelins | 2 | 2020 | 22 | 0.070 |
Why?
| | Phosphoproteins | 1 | 2010 | 338 | 0.070 |
Why?
| | Group IV Phospholipases A2 | 2 | 2019 | 47 | 0.070 |
Why?
| | Vasoconstriction | 1 | 2009 | 219 | 0.070 |
Why?
| | Reactive Oxygen Species | 2 | 2023 | 630 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2526 | 0.070 |
Why?
| | Interleukin-1beta | 2 | 2021 | 380 | 0.070 |
Why?
| | Glucose | 2 | 2023 | 1041 | 0.070 |
Why?
| | Inflammation | 3 | 2024 | 2890 | 0.070 |
Why?
| | Diet, Western | 2 | 2018 | 82 | 0.070 |
Why?
| | Transcriptional Activation | 1 | 2009 | 378 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 3 | 2018 | 2520 | 0.070 |
Why?
| | Cognition | 1 | 2015 | 1222 | 0.070 |
Why?
| | Pulmonary Fibrosis | 1 | 2011 | 400 | 0.070 |
Why?
| | Child | 6 | 2024 | 22308 | 0.070 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2021 | 2132 | 0.070 |
Why?
| | Biomedical Research | 1 | 2013 | 703 | 0.070 |
Why?
| | Disease Susceptibility | 2 | 2019 | 352 | 0.060 |
Why?
| | Phenotype | 4 | 2018 | 3166 | 0.060 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2013 | 918 | 0.060 |
Why?
| | Curriculum | 1 | 2013 | 1033 | 0.060 |
Why?
| | Exercise | 1 | 2018 | 2103 | 0.060 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2008 | 369 | 0.060 |
Why?
| | Heart Failure | 1 | 2019 | 2088 | 0.060 |
Why?
| | Pulmonary Alveoli | 1 | 2009 | 410 | 0.060 |
Why?
| | Staphylococcal Infections | 1 | 2011 | 392 | 0.060 |
Why?
| | Peptide Fragments | 1 | 2010 | 698 | 0.060 |
Why?
| | Fibroblasts | 1 | 2011 | 1020 | 0.060 |
Why?
| | Xanthophylls | 1 | 2025 | 18 | 0.060 |
Why?
| | Isomerism | 1 | 2025 | 56 | 0.060 |
Why?
| | Iodine | 1 | 2025 | 27 | 0.060 |
Why?
| | Mice, Inbred BALB C | 2 | 2019 | 1274 | 0.060 |
Why?
| | Food Handling | 1 | 2025 | 66 | 0.060 |
Why?
| | Algal Proteins | 1 | 2004 | 6 | 0.050 |
Why?
| | Multienzyme Complexes | 1 | 2004 | 66 | 0.050 |
Why?
| | Cysteine Endopeptidases | 1 | 2004 | 74 | 0.050 |
Why?
| | Choline | 1 | 2025 | 133 | 0.050 |
Why?
| | Cryptochromes | 1 | 2004 | 25 | 0.050 |
Why?
| | Gene Deletion | 1 | 2025 | 388 | 0.050 |
Why?
| | Antigen-Antibody Reactions | 1 | 2003 | 54 | 0.050 |
Why?
| | Oxazoles | 1 | 2003 | 38 | 0.050 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2019 | 281 | 0.050 |
Why?
| | Protein Binding | 2 | 2020 | 2239 | 0.050 |
Why?
| | Protoplasts | 1 | 2003 | 7 | 0.050 |
Why?
| | Down-Regulation | 2 | 2020 | 641 | 0.050 |
Why?
| | Quality Control | 1 | 2023 | 171 | 0.050 |
Why?
| | RNA, Small Interfering | 2 | 2018 | 626 | 0.050 |
Why?
| | Cholesterol, HDL | 1 | 2023 | 196 | 0.050 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2004 | 161 | 0.050 |
Why?
| | Introns | 1 | 2004 | 254 | 0.050 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2022 | 10 | 0.050 |
Why?
| | Enzyme Activation | 2 | 2019 | 811 | 0.050 |
Why?
| | Polyunsaturated Alkamides | 1 | 2022 | 10 | 0.050 |
Why?
| | Microscopy, Electron | 1 | 2003 | 441 | 0.050 |
Why?
| | Receptors, Cannabinoid | 1 | 2022 | 16 | 0.050 |
Why?
| | Virus Assembly | 1 | 2003 | 79 | 0.050 |
Why?
| | Exons | 1 | 2004 | 353 | 0.050 |
Why?
| | Young Adult | 5 | 2020 | 13673 | 0.050 |
Why?
| | National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2022 | 25 | 0.050 |
Why?
| | Recombinant Proteins | 2 | 2020 | 1357 | 0.050 |
Why?
| | Patient Acuity | 1 | 2022 | 47 | 0.050 |
Why?
| | Epithelial Cells | 2 | 2024 | 1110 | 0.050 |
Why?
| | Seeds | 1 | 2003 | 85 | 0.050 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2022 | 45 | 0.050 |
Why?
| | Mutation | 2 | 2004 | 4013 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2004 | 398 | 0.050 |
Why?
| | Cholecalciferol | 1 | 2022 | 61 | 0.050 |
Why?
| | Diet, Carbohydrate-Restricted | 1 | 2022 | 37 | 0.050 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 3469 | 0.050 |
Why?
| | Double-Blind Method | 2 | 2018 | 1983 | 0.050 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2022 | 133 | 0.050 |
Why?
| | HeLa Cells | 1 | 2003 | 640 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2008 | 1154 | 0.050 |
Why?
| | Dietary Carbohydrates | 1 | 2022 | 153 | 0.040 |
Why?
| | Immunity | 1 | 2022 | 140 | 0.040 |
Why?
| | Polymorphism, Genetic | 1 | 2024 | 625 | 0.040 |
Why?
| | Cattle | 1 | 2024 | 998 | 0.040 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2020 | 18 | 0.040 |
Why?
| | 3T3-L1 Cells | 1 | 2020 | 37 | 0.040 |
Why?
| | Adolescent | 4 | 2020 | 22007 | 0.040 |
Why?
| | Leptin | 1 | 2022 | 242 | 0.040 |
Why?
| | Sirtuin 2 | 1 | 2020 | 24 | 0.040 |
Why?
| | Adenosine | 1 | 2022 | 244 | 0.040 |
Why?
| | Phosphatidylinositols | 1 | 2020 | 59 | 0.040 |
Why?
| | Prescriptions | 1 | 2021 | 73 | 0.040 |
Why?
| | Oxidative Phosphorylation | 1 | 2021 | 200 | 0.040 |
Why?
| | Glutamic Acid | 1 | 2022 | 256 | 0.040 |
Why?
| | Phosphatidylserines | 1 | 2020 | 88 | 0.040 |
Why?
| | Phosphatidylethanolamines | 1 | 2020 | 76 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2020 | 111 | 0.040 |
Why?
| | Neurons | 2 | 2023 | 1619 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2022 | 2902 | 0.040 |
Why?
| | Receptors, Chemokine | 1 | 2020 | 49 | 0.040 |
Why?
| | Metaplasia | 1 | 2020 | 58 | 0.040 |
Why?
| | Sex Factors | 2 | 2018 | 2058 | 0.040 |
Why?
| | Placental Insufficiency | 1 | 2021 | 125 | 0.040 |
Why?
| | Adipose Tissue, White | 1 | 2020 | 43 | 0.040 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2021 | 216 | 0.040 |
Why?
| | Triglycerides | 1 | 2022 | 514 | 0.040 |
Why?
| | Synaptic Transmission | 1 | 2022 | 295 | 0.040 |
Why?
| | Calcium Signaling | 2 | 2015 | 250 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2021 | 273 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2020 | 150 | 0.040 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2020 | 55 | 0.040 |
Why?
| | Cohort Studies | 2 | 2021 | 5799 | 0.040 |
Why?
| | Lipid Bilayers | 1 | 2020 | 106 | 0.040 |
Why?
| | Cloning, Molecular | 1 | 2020 | 533 | 0.040 |
Why?
| | Water | 1 | 2003 | 464 | 0.040 |
Why?
| | Nutritional Sciences | 1 | 2020 | 44 | 0.040 |
Why?
| | Neutrophils | 1 | 2025 | 1282 | 0.040 |
Why?
| | Pregnancy Trimester, Third | 1 | 2020 | 117 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 118 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 2 | 2021 | 2363 | 0.040 |
Why?
| | Cellular Reprogramming | 1 | 2020 | 99 | 0.040 |
Why?
| | Ultrasonography, Doppler | 1 | 2020 | 122 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2020 | 336 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2003 | 653 | 0.040 |
Why?
| | Piperidines | 1 | 2021 | 216 | 0.040 |
Why?
| | Vitamin D | 1 | 2022 | 397 | 0.040 |
Why?
| | Crystallography, X-Ray | 1 | 2020 | 485 | 0.040 |
Why?
| | Methylation | 1 | 2019 | 230 | 0.040 |
Why?
| | Biological Transport | 1 | 2020 | 407 | 0.040 |
Why?
| | Infant, Small for Gestational Age | 1 | 2020 | 104 | 0.040 |
Why?
| | Sheep | 1 | 2021 | 874 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2003 | 560 | 0.040 |
Why?
| | Interferons | 1 | 2020 | 195 | 0.040 |
Why?
| | Glucose Intolerance | 1 | 2020 | 147 | 0.040 |
Why?
| | Cilia | 1 | 2020 | 172 | 0.040 |
Why?
| | Citric Acid Cycle | 1 | 2018 | 58 | 0.040 |
Why?
| | Molecular Weight | 1 | 2019 | 329 | 0.040 |
Why?
| | Fibrinogen | 2 | 2010 | 180 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2020 | 246 | 0.040 |
Why?
| | Lymphocyte Count | 1 | 2018 | 167 | 0.040 |
Why?
| | Microglia | 1 | 2021 | 255 | 0.040 |
Why?
| | Animals, Newborn | 1 | 2021 | 863 | 0.040 |
Why?
| | Cyclooxygenase 2 | 1 | 2019 | 176 | 0.040 |
Why?
| | Germinal Center | 1 | 2018 | 66 | 0.040 |
Why?
| | Metagenomics | 1 | 2020 | 182 | 0.040 |
Why?
| | GTP Phosphohydrolases | 1 | 2018 | 93 | 0.040 |
Why?
| | Caspase 1 | 1 | 2018 | 147 | 0.040 |
Why?
| | Models, Molecular | 1 | 2003 | 1603 | 0.040 |
Why?
| | Native Polyacrylamide Gel Electrophoresis | 1 | 2018 | 3 | 0.040 |
Why?
| | Naphthoquinones | 1 | 2018 | 18 | 0.040 |
Why?
| | Pyridinium Compounds | 1 | 2018 | 28 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2019 | 386 | 0.030 |
Why?
| | Ultrasonography, Prenatal | 1 | 2020 | 291 | 0.030 |
Why?
| | Methionine | 1 | 2018 | 159 | 0.030 |
Why?
| | Phospholipase A2 Inhibitors | 1 | 2017 | 3 | 0.030 |
Why?
| | Predictive Value of Tests | 2 | 2015 | 2070 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2021 | 1261 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2018 | 154 | 0.030 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 156 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1556 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2021 | 1490 | 0.030 |
Why?
| | Lysine | 1 | 2019 | 292 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2018 | 325 | 0.030 |
Why?
| | Energy Intake | 1 | 2020 | 513 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2017 | 33 | 0.030 |
Why?
| | Forensic Medicine | 1 | 2017 | 17 | 0.030 |
Why?
| | Weight Loss | 1 | 2022 | 789 | 0.030 |
Why?
| | Transfection | 1 | 2019 | 943 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2017 | 2828 | 0.030 |
Why?
| | Pyridines | 1 | 2021 | 510 | 0.030 |
Why?
| | Nutritional Status | 1 | 2020 | 362 | 0.030 |
Why?
| | Fetus | 1 | 2021 | 802 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2020 | 457 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2018 | 224 | 0.030 |
Why?
| | Pyrrolidines | 1 | 2017 | 90 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2018 | 330 | 0.030 |
Why?
| | Circadian Rhythm | 1 | 2021 | 508 | 0.030 |
Why?
| | Caloric Restriction | 1 | 2018 | 124 | 0.030 |
Why?
| | Tissue Donors | 1 | 2019 | 405 | 0.030 |
Why?
| | Family | 1 | 2021 | 680 | 0.030 |
Why?
| | RNA-Binding Proteins | 2 | 2011 | 440 | 0.030 |
Why?
| | Gestational Age | 1 | 2020 | 957 | 0.030 |
Why?
| | Influenza A virus | 1 | 2017 | 111 | 0.030 |
Why?
| | Escherichia coli | 1 | 2020 | 838 | 0.030 |
Why?
| | Methemoglobin | 1 | 2015 | 21 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2018 | 313 | 0.030 |
Why?
| | DNA Damage | 1 | 2019 | 427 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2017 | 579 | 0.030 |
Why?
| | Body Mass Index | 2 | 2015 | 2382 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2021 | 1250 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 2017 | 287 | 0.030 |
Why?
| | Hydrogen Peroxide | 1 | 2017 | 339 | 0.030 |
Why?
| | Clone Cells | 1 | 2016 | 266 | 0.030 |
Why?
| | Etiocholanolone | 1 | 2015 | 6 | 0.030 |
Why?
| | Ranolazine | 1 | 2015 | 25 | 0.030 |
Why?
| | Trihexosylceramides | 1 | 2015 | 4 | 0.030 |
Why?
| | Gerbillinae | 1 | 2015 | 71 | 0.030 |
Why?
| | Thiocyanates | 1 | 2015 | 30 | 0.030 |
Why?
| | Placenta | 1 | 2021 | 761 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2015 | 2892 | 0.030 |
Why?
| | Elasticity | 1 | 2015 | 194 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2021 | 1402 | 0.030 |
Why?
| | Pulse Wave Analysis | 1 | 2015 | 237 | 0.030 |
Why?
| | Cardiotonic Agents | 1 | 2015 | 95 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 814 | 0.030 |
Why?
| | Prospective Studies | 2 | 2021 | 7739 | 0.030 |
Why?
| | Mitochondria, Heart | 1 | 2015 | 102 | 0.030 |
Why?
| | Chronic Disease | 1 | 2020 | 1816 | 0.030 |
Why?
| | Brachial Artery | 1 | 2015 | 204 | 0.030 |
Why?
| | Child, Preschool | 1 | 2009 | 11457 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2794 | 0.030 |
Why?
| | Molecular Targeted Therapy | 1 | 2017 | 419 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2017 | 372 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 852 | 0.030 |
Why?
| | Salmeterol Xinafoate | 1 | 2013 | 22 | 0.030 |
Why?
| | Time Factors | 2 | 2019 | 6956 | 0.030 |
Why?
| | Fluticasone | 1 | 2013 | 56 | 0.030 |
Why?
| | Cyclopropanes | 1 | 2013 | 71 | 0.030 |
Why?
| | Immune Tolerance | 1 | 2016 | 368 | 0.030 |
Why?
| | Pregnenolone | 1 | 2013 | 3 | 0.030 |
Why?
| | Androstadienes | 1 | 2013 | 78 | 0.030 |
Why?
| | Albuterol | 1 | 2013 | 75 | 0.030 |
Why?
| | Disease Progression | 1 | 2021 | 2793 | 0.030 |
Why?
| | Acetates | 1 | 2013 | 79 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2013 | 328 | 0.020 |
Why?
| | Sulfides | 1 | 2013 | 82 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 2064 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 434 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 346 | 0.020 |
Why?
| | Quinolines | 1 | 2013 | 160 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2015 | 492 | 0.020 |
Why?
| | Colorado | 1 | 2022 | 4610 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2013 | 215 | 0.020 |
Why?
| | Vasodilation | 1 | 2015 | 516 | 0.020 |
Why?
| | Forced Expiratory Volume | 1 | 2013 | 489 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2018 | 932 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2013 | 372 | 0.020 |
Why?
| | Mesocricetus | 1 | 2011 | 45 | 0.020 |
Why?
| | Interleukin-2 | 1 | 2013 | 453 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1865 | 0.020 |
Why?
| | Fas Ligand Protein | 1 | 2011 | 60 | 0.020 |
Why?
| | Antioxidants | 1 | 2015 | 595 | 0.020 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 145 | 0.020 |
Why?
| | Cricetinae | 1 | 2011 | 301 | 0.020 |
Why?
| | Antigen-Presenting Cells | 1 | 2011 | 159 | 0.020 |
Why?
| | Regression Analysis | 1 | 2013 | 1020 | 0.020 |
Why?
| | Eosinophils | 1 | 2013 | 326 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 855 | 0.020 |
Why?
| | Salts | 1 | 2010 | 37 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2015 | 900 | 0.020 |
Why?
| | Myocytes, Cardiac | 1 | 2015 | 535 | 0.020 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2010 | 85 | 0.020 |
Why?
| | Adrenal Cortex Hormones | 1 | 2013 | 501 | 0.020 |
Why?
| | HLA-A Antigens | 1 | 2010 | 58 | 0.020 |
Why?
| | Surgical Tape | 1 | 2009 | 5 | 0.020 |
Why?
| | Endothelin-Converting Enzymes | 1 | 2009 | 9 | 0.020 |
Why?
| | Fibrin | 1 | 2010 | 91 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2011 | 596 | 0.020 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2009 | 31 | 0.020 |
Why?
| | Metalloendopeptidases | 1 | 2009 | 59 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2013 | 792 | 0.020 |
Why?
| | alpha-2-HS-Glycoprotein | 1 | 2009 | 2 | 0.020 |
Why?
| | Immunoglobulin J-Chains | 1 | 2009 | 6 | 0.020 |
Why?
| | Thrombin | 1 | 2010 | 170 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2010 | 225 | 0.020 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2009 | 33 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 5636 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 309 | 0.020 |
Why?
| | Haptoglobins | 1 | 2009 | 56 | 0.020 |
Why?
| | Risk | 1 | 2011 | 904 | 0.020 |
Why?
| | Albumins | 1 | 2009 | 115 | 0.020 |
Why?
| | Phosphotyrosine | 1 | 2008 | 40 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2020 | 6275 | 0.020 |
Why?
| | alpha 1-Antitrypsin | 1 | 2009 | 104 | 0.020 |
Why?
| | Endothelin-1 | 1 | 2009 | 177 | 0.020 |
Why?
| | Drug Interactions | 1 | 2009 | 406 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2008 | 93 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 1444 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 175 | 0.020 |
Why?
| | Nanotechnology | 1 | 2008 | 124 | 0.020 |
Why?
| | Blood Proteins | 1 | 2009 | 250 | 0.020 |
Why?
| | Protein Conformation | 1 | 2010 | 941 | 0.020 |
Why?
| | Staphylococcus aureus | 1 | 2011 | 437 | 0.020 |
Why?
| | Lymphoma | 1 | 2008 | 228 | 0.020 |
Why?
| | Cell Cycle | 1 | 2009 | 597 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2011 | 874 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2008 | 444 | 0.020 |
Why?
| | Age Factors | 1 | 2013 | 3292 | 0.010 |
Why?
| | Cell Membrane | 1 | 2009 | 724 | 0.010 |
Why?
| | Algorithms | 1 | 2013 | 1763 | 0.010 |
Why?
| | Histones | 1 | 2010 | 639 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 2009 | 900 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2009 | 1242 | 0.010 |
Why?
| | United States | 1 | 2022 | 15220 | 0.010 |
Why?
| | Pyrimidines | 1 | 2008 | 477 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1764 | 0.010 |
Why?
| | Raffinose | 1 | 2003 | 23 | 0.010 |
Why?
| | Germination | 1 | 2003 | 7 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2746 | 0.010 |
Why?
| | Sucrose | 1 | 2003 | 111 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2010 | 2002 | 0.010 |
Why?
| | Vaccination | 1 | 2010 | 1467 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2008 | 1448 | 0.010 |
Why?
| | Risk Factors | 1 | 2015 | 10438 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2011 | 5929 | 0.010 |
Why?
|
|
Reisdorph's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|